STREAMEX CORP. Marketable Securities
STREAMEX CORP. (STEX) had Marketable Securities of $12.98 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2026-08-14
- 2026-06-30: Marketable Securities $12.98M.
- 2026-03-31: Marketable Securities $23.77M.
- 2026-02-26: Marketable Securities $23.90M.
- 2025-12-31: Marketable Securities $9.71M.
| Period end | Marketable Securities |
|---|---|
| 2026-06-30 | $12.98M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $23.77M 10-Q · filed 2026-05-14 |
| 2026-02-26 | $23.90M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.71M 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |